Your account is not claimed yet. You can sign up with ORCID to claim your account.

Fleur S Peters (F S Peters)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

AMC

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AMC Apr 15o 2019

Netherlands

Postdoctoral Researcher :: Experimental Immunology

Publications

Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia 37 (3) (2023)
Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia (2023)
Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia 37 (3) (2023)
Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia (2023)
Chiara Montironi, Chaja Feige Jacobs, Gaspard Cretenet, Fleur S Peters, Bauke V Schomakers, Michel van Weeghel, Arnon P Kater, Helga Simon-Molas, Eric Eldering
T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia. Blood advances (2023)
Anne W J Martens, Inga Kavazović, Mia Krapić, Su Min Pack, Ramon Arens, Aldo Jongejan, Perry D Moerland, Eric Eldering, Gerritje J W van der Windt, Felix M Wensveen, Fleur S Peters, Arnon P Kater
Chronic lymphocytic leukemia presence impairs antigen-specific CD8 + T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia 37 (3) (2023)
Fleur S Peters, Arnon P Kater
Increasing CART cell engine performance in CLL. Blood 139 (4) (2022)
J A C van Bruggen, G J W van der Windt, M Hoogendoorn, J Dubois, Arnon P Kater, Fleur S Peters
Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells. Blood advances 6 (14) (2022)
Zhenghao Chen, Helga Simon-Molas, Gaspard Cretenet, Beatriz Valle-Argos, Lindsay D Smith, Francesco Forconi, Bauke V Schomakers, Michel van Weeghel, Dean J Bryant, Jaco A C van Bruggen, Fleur S Peters, Jeffrey C Rathmell, Gerritje J W van der Windt, Arnon P Kater, Graham Packham, Eric Eldering
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood 140 (6) (2022)
Ide T Spaanderman, Fleur S Peters, Aldo Jongejan, Egbert J W Redeker, Cornelis J A Punt, Adriaan D Bins
Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer. PloS one 16 (6) (2021)
Fleur S Peters, A M A Peeters, T P P van den Bosch, A L Mooyaart, J van de Wetering, M G H Betjes, C C Baan, K Boer
Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer. Clinical and experimental immunology 197 (3) (2019)
Fleur S Peters, Annemiek M A Peeters, Pooja R Mandaviya, Joyce B J van Meurs, Leo J Hofland, Jacqueline van de Wetering, Michiel G H Betjes, Carla C Baan, Karin Boer
Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer. Clinical epigenetics 10 (2018)

Fleur S Peters.css-eqlu8i{font-size:small;padding-left:4px;} (F S Peters)

Publication Activity (10 Years)

Top Topics

Top Venues

Fleur S Peters (F S Peters)